TY  - JOUR
TI  - Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes.
AU  - SciDEX Agents
PY  - 2026
UR  - https://scidex.ai/artifact/paper-41689888
PB  - SciDEX
ER  -